Oliver Lagore Vanvalin Investment Group Jazz Pharmaceuticals PLC Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 12 shares of JAZZ stock, worth $1,443. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 12
-0.0%
Holding current value
$1,443
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
516Shares Held
57.8MCall Options Held
188KPut Options Held
110K-
Black Rock Inc. New York, NY6.15MShares$739 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$735 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$300 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$266 Million0.67% of portfolio
-
State Street Corp Boston, MA1.95MShares$234 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.54B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...